After transdermal E2 treatment , E1S levels increased significantly , yet to a much lesser extent , reaching levels of 1.8 ng/mL and 3.2 ng/mL after 9 months of treatment with the 0.05 mg/day and 0.1 mg/day patches , respectively .
